- Home
- EXPO vs IMVT Comparison
EXPO vs IMVT Comparison
Compare EXPO & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPO
- IMVT
- Stock Information
- Founded
- EXPO 1967
- IMVT N/A
- Country
- EXPO United States
- IMVT United States
- Employees
- EXPO N/A
- IMVT N/A
- Industry
- EXPO Professional Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXPO Consumer Discretionary
- IMVT Health Care
- Exchange
- EXPO Nasdaq
- IMVT Nasdaq
- Market Cap
- EXPO 4.1B
- IMVT 3.4B
- IPO Year
- EXPO 1990
- IMVT N/A
- Fundamental
- Price
- EXPO $80.78
- IMVT $15.20
- Analyst Decision
- EXPO Strong Buy
- IMVT Strong Buy
- Analyst Count
- EXPO 1
- IMVT 11
- Target Price
- EXPO $120.00
- IMVT $44.13
- AVG Volume (30 Days)
- EXPO 328.6K
- IMVT 2.0M
- Earning Date
- EXPO 04-24-2025
- IMVT 02-06-2025
- Dividend Yield
- EXPO 1.48%
- IMVT N/A
- EPS Growth
- EXPO 8.76
- IMVT N/A
- EPS
- EXPO 2.11
- IMVT N/A
- Revenue
- EXPO $518,490,000.00
- IMVT N/A
- Revenue This Year
- EXPO $4.77
- IMVT $108.88
- Revenue Next Year
- EXPO $7.69
- IMVT N/A
- P/E Ratio
- EXPO $38.42
- IMVT N/A
- Revenue Growth
- EXPO 4.28
- IMVT N/A
- 52 Week Low
- EXPO $77.30
- IMVT $15.00
- 52 Week High
- EXPO $115.75
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- EXPO 39.85
- IMVT 28.92
- Support Level
- EXPO $79.50
- IMVT $17.49
- Resistance Level
- EXPO $82.61
- IMVT $18.96
- Average True Range (ATR)
- EXPO 1.63
- IMVT 1.33
- MACD
- EXPO 0.25
- IMVT -0.26
- Stochastic Oscillator
- EXPO 43.51
- IMVT 3.68
About EXPO Exponent Inc.
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).